[Host factors determining the outcome of IFN treatment for chronic hepatitis C].
Kiyosawa
Kendo
K
Internal Medicine, Shinshu University School of Medicine.
D000428:Alcohol Drinking; D017951:Antigen Presentation / Q000235:genetics; D000998:Antiviral Agents / Q000627:therapeutic use*; D015992:Body Mass Index; D005355:Fibrosis; D006680:HLA Antigens / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D016753:Interleukin-10 / Q000235:genetics; D008099:Liver / Q000473:pathology; D010976:Platelet Count; D011110:Polymorphism, Genetic; D019713:Receptors, CCR5 / Q000235:genetics; D017471:Receptors, Interferon / Q000378:metabolism; D012307:Risk Factors; D016896:Treatment Outcome
D000998:Antiviral Agents; D006680:HLA Antigens; D019713:Receptors, CCR5; D017471:Receptors, Interferon; D016753:Interleukin-10; D007372:Interferons